Cargando…
Stability of the cancer target DDIAS is regulated by the CHIP/HSP70 pathway in lung cancer cells
DNA damage-induced apoptosis suppressor (DDIAS) rescues lung cancer cells from apoptosis in response to DNA damage. DDIAS is transcriptionally activated by NFATc1 and EGF-mediated ERK5/MEF2B, leading to cisplatin resistance and cell invasion. Therefore, DDIAS is suggested as a therapeutic target for...
Autores principales: | Won, Kyoung-Jae, Im, Joo-Young, Kim, Bo-Kyung, Ban, Hyun Seung, Jung, Young-Jin, Jung, Kyeong Eun, Won, Misun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386388/ https://www.ncbi.nlm.nih.gov/pubmed/28079882 http://dx.doi.org/10.1038/cddis.2016.488 |
Ejemplares similares
-
Data on the transcriptional regulation of DNA damage induced apoptosis suppressor (DDIAS) by ERK5/MEF2B pathway in lung cancer cells
por: Im, Joo-Young, et al.
Publicado: (2016) -
DDIAS, DNA damage-induced apoptosis suppressor, is a potential therapeutic target in cancer
por: Im, Joo-Young, et al.
Publicado: (2023) -
DDIAS promotes STAT3 activation by preventing STAT3 recruitment to PTPRM in lung cancer cells
por: Im, Joo-Young, et al.
Publicado: (2020) -
DGG-100629 inhibits lung cancer growth by suppressing the NFATc1/DDIAS/STAT3 pathway
por: Im, Joo-Young, et al.
Publicado: (2021) -
Alterations of the Hsp70/Hsp90 chaperone and the HOP/CHIP co-chaperone system in cancer
por: Ruckova, Eva, et al.
Publicado: (2012)